Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03893903
Title AMPLIFYing NEOepitope-specific VACcine Responses in Progressive Diffuse Glioma (AMPLIFY-NEOVAC)
Acronym AMPLIFY-NEOVAC
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors German Cancer Research Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Charité Berlin, Neurosurgery Berlin Germany Details
University Hospital Dresden, Neurosurgery Dresden Germany Details
Essen University Hospital, Neurooncology Essen Germany Details
University Hospital Frankfurt, Neurooncology Frankfurt/Main Germany Details
University Hospital Freiburg, Neurosurgery Freiburg Germany Details
University Hospital Heidelberg, Neurology Clinic Heidelberg Germany Details
Mannheim University Hospital Mannheim Germany Details
LMU, University Hospital Munich Munich Germany Details
Katharinenhospital Stuttgart, Neurosurgery Stuttgart Germany Details
University Hospital Tuebingen, Neurooncology Tuebingen Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field